Morra B, Beatrice F, Cavallo G P, Bussi M, Di Fortunato V, Poggio E, Vercellino M, Vercellino M, Cortesina G
Laryngoscope. 1984 Jun;94(6):825-8. doi: 10.1288/00005537-198406000-00019.
The specific tumor-induced leukocyte inhibition factor (LIF) production in laryngeal cancer patients has been investigated before and after the removal of adherent cells in order to evaluate the existence of a suppressor activity; 20 patients served as subject. The LIF production, after challenging the lymphocytes with 3MKC1 autologous tumor extracts, was significant in 12 patients and showed a further significant increase after the removal of adherent cells. In 3 patients with no previous significant LIF production, there was a conversion to significance when the adherent cells were removed. The other patients did not show any significant variation. These data seem to suggest the existence of a suppressor activity exerted by adherent cells in laryngeal cancer patients on LIF production.
为评估抑制活性的存在,研究了喉癌患者在去除贴壁细胞前后特异性肿瘤诱导白细胞抑制因子(LIF)的产生情况;以20例患者为研究对象。用3MKC1自体肿瘤提取物刺激淋巴细胞后,12例患者的LIF产生显著,去除贴壁细胞后LIF产生进一步显著增加。在3例先前LIF产生无显著变化的患者中,去除贴壁细胞后转变为有显著变化。其他患者未显示任何显著变化。这些数据似乎表明喉癌患者中的贴壁细胞对LIF产生具有抑制活性。